Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
Ulises Orlando(University of Buenos Aires), Ernesto J. Podestá(University of Buenos Aires)
Cited by 51
Related Papers
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis
|Cellular and Molecular Life Sciences|2020|75